Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Kamiya Mehla and Surendra Shukla.
Kamiya Mehla
Connection Strength
2.332
Surendra Shukla
  1. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia. Cancer Lett. 2020 08 01; 484:29-39.
    View in: PubMed
    Score: 0.648
  2. Systemic immunosuppression limits NK cell therapy efficacy in pancreatic cancer. Mol Cancer. 2026 Jul 08; 25(1).
    View in: PubMed
    Score: 0.249
  3. Vitamin B6 competition in the tumor microenvironment hampers antitumor functions of NK cells. Cancer Discov. 2023 Nov 07.
    View in: PubMed
    Score: 0.207
  4. IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer. Mol Cancer Ther. 2021 12; 20(12):2457-2468.
    View in: PubMed
    Score: 0.179
  5. MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. Cancer Cell. 2017 09 11; 32(3):392.
    View in: PubMed
    Score: 0.135
  6. MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. Cancer Cell. 2017 07 10; 32(1):71-87.e7.
    View in: PubMed
    Score: 0.133
  7. Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth. Oncotarget. 2015 Dec 01; 6(38):41146-61.
    View in: PubMed
    Score: 0.119
  8. Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia. Cancer Metab. 2014; 2:18.
    View in: PubMed
    Score: 0.109
  9. Spatial transcriptome mapping identifies Ppara-Anxa2 cross-talk in microplastic-induced hepatotoxicity. Sci Adv. 2026 Jun 19; 12(25):eaec8681.
    View in: PubMed
    Score: 0.062
  10. KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer. Cancer Res. 2026 Apr 29.
    View in: PubMed
    Score: 0.061
  11. DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation. Elife. 2024 Jul 08; 12.
    View in: PubMed
    Score: 0.054
  12. Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Nat Cell Biol. 2024 May; 26(5):840.
    View in: PubMed
    Score: 0.053
  13. The MUC1-HIF-1a signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling. Proc Natl Acad Sci U S A. 2024 Apr 02; 121(14):e2315509121.
    View in: PubMed
    Score: 0.053
  14. Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Nat Cell Biol. 2024 Mar 01.
    View in: PubMed
    Score: 0.053
  15. DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation. bioRxiv. 2023 Apr 05.
    View in: PubMed
    Score: 0.050
  16. CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis. Oncogene. 2022 02; 41(7):971-982.
    View in: PubMed
    Score: 0.046
  17. Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Gastroenterology. 2021 11; 161(5):1584-1600.
    View in: PubMed
    Score: 0.044
  18. SIRT1-NOX4 signaling axis regulates cancer cachexia. J Exp Med. 2020 07 06; 217(7).
    View in: PubMed
    Score: 0.041
  19. Microscale Gene Expression Analysis of Tumor-Associated Macrophages. Sci Rep. 2018 02 05; 8(1):2408.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.